Cargando…
Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
Autores principales: | Trivedi, Mehul, Gupta, Samir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632816/ https://www.ncbi.nlm.nih.gov/pubmed/34863791 http://dx.doi.org/10.1053/j.gastro.2021.11.030 |
Ejemplares similares
-
Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012) -
Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021) -
Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996) -
Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)
por: Allison, James E., et al.
Publicado: (2014) -
The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City
por: Caron, Mireille, et al.
Publicado: (2018)